SMAD4 and cancer: In cancer cells, a panel of 4 missense mutations in the MH1 domain of Smad4 identified in human pancreatic and colorectal cancers was reported to render the mutant Smad4 a better substrate for poly-ubiquitin modification and proteasome-mediated degradation [20].